The 71-year-old had previously had leukemia and atrial fibrillation, an irregular heart rhythm, the report from the District Six Medical Examiner also said.

After a blowout quarterly earnings report this week, Palantir has become one of the buzziest (and most expensive) stocks on Wall Street.